Is use of vitamin K antagonists associated with the risk of prostate cancer?: A meta-analysis

BACKGROUND: Vitamin K antagonists (VKAs) may have potential antitumor effects in prostate cancer. However, the findings of observational studies are inconsistent. The purpose of the present study was to estimate the quantitative association between VKAs use and prostate cancer risk by combining the...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jin-Dan, Luo, Jie, Lai, Chong, Chen, Jun, Meng, Hong-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310569/
https://www.ncbi.nlm.nih.gov/pubmed/30544443
http://dx.doi.org/10.1097/MD.0000000000013489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310569/
https://www.ncbi.nlm.nih.gov/pubmed/30544443
http://dx.doi.org/10.1097/MD.0000000000013489

Ejemplares similares